Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2011-05-05
2011-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety, Tolerability And On-Body Temperature Of A Disposable Heatwrap Device For The Lower Back
NCT01055262
Identifying the Limits of Survivability in Heat-exposed Older Females
NCT07032493
Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)
NCT02241057
Passive Heat Therapy and Age-associated Physiological Function
NCT03264508
Cryotherapy and Body Slimming
NCT04287153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment A
thermal therapy
thermal therapy
heat therapy device, topical, two applications, at 0-3 hours and 4-6 hours on treatment day
Treatment B
ThermaCare Lower Back/Hip heatwrap
ThermaCare heatwrap
heatwrap, topical, one time application, 8 hour duration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
thermal therapy
heat therapy device, topical, two applications, at 0-3 hours and 4-6 hours on treatment day
ThermaCare heatwrap
heatwrap, topical, one time application, 8 hour duration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* or 55-84 years of age and with a body mass index ≥ 30 kg/m2 or \< 30 kg/m2
* Females who are not pregnant or breastfeeding
* Subject is medically cleared for study participation
Exclusion Criteria
* Diabetes
* Any active skin disease or tattoos at the test site that would affect participation
18 Years
84 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University
Loma Linda, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TC-09-12
Identifier Type: OTHER
Identifier Source: secondary_id
B3571002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.